Longitudinal Assessment of Enhancing Foci of Abnormal Signal Intensity in Neurofibromatosis Type 1

References

1. 1.↵
   1. Aoki S,
   2. Barkovich AJ,
   3. Nishimura K, et al

   . Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 1989;172:527–34 doi:10.1148/radiology.172.2.2501822 pmid:2501822

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Williams VC,
   2. Lucas J,
   3. Babcock MA, et al

   . Neurofibromatosis type 1 revisited. Pediatrics 2009;123:124–33 doi:10.1542/peds.2007-3204 pmid:19117870

   Abstract/FREE Full Text
3. 3.↵
   1. Mentzel H-J,
   2. Seidel J,
   3. Fitzek C, et al

   . Pediatric brain MRI in neurofibromatosis type I. Eur Radiol 2005;15:814–22 doi:10.1007/s00330-004-2433-y pmid:15290066

   CrossRefPubMed
4. 4.↵
   1. DiMario FJ,
   2. Ramsby G,
   3. Greenstein R, et al

   . Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol 1993;8:32–39 doi:10.1177/088307389300800105 pmid:8445170

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Itoh T,
   2. Magnaldi S,
   3. White RM, et al

   . Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994;15:1513–19 pmid:7985572

   Abstract/FREE Full Text
6. 6.↵
   1. Griffiths PD,
   2. Blaser S,
   3. Mukonoweshuro W, et al

   . Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 1999;104:e49 doi:10.1542/peds.104.4.e49 pmid:10506274

   Abstract/FREE Full Text
7. 7.↵
   1. Duffner PK,
   2. Cohen ME,
   3. Seidel FG, et al

   . The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373–78 doi:10.1212/wnl.39.3.373 pmid:2494565

   Abstract/FREE Full Text
8. 8.↵
   1. DiMario FJ,
   2. Ramsby G

   . Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 1998;55:500–05 doi:10.1001/archneur.55.4.500 pmid:9561977

   CrossRefPubMedWeb of Science
9. 9.↵
   1. DiPaolo DP,
   2. Zimmerman RA,
   3. Rorke LB, et al

   . Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995;195:721–24 doi:10.1148/radiology.195.3.7754001 pmid:7754001

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Cecen E,
    2. Ince D,
    3. Uysal KM, et al

    . Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1. Childs Nerv Syst 2011;27:1885–93 doi:10.1007/s00381-011-1425-x pmid:21442270

    CrossRefPubMed
11. 11.↵
    1. Vinchon M,
    2. Soto-Ares G,
    3. Ruchoux MM, et al

    . Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv Syst 2000;16:417–20 doi:10.1007/PL00007285 pmid:10958550

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Guillamo J-S,
    2. Créange A,
    3. Kalifa C, et al

    . Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain J Neurol 2003;126:152–60 doi:10.1093/brain/awg016 pmid:12477702

    CrossRefPubMed
13. 13.↵
    1. Molloy PT,
    2. Bilaniuk LT,
    3. Vaughan SN, et al

    . Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 1995;45:1897–902 doi:10.1212/wnl.45.10.1897 pmid:7477989

    Abstract/FREE Full Text
14. 14.↵
    1. Ratner N,
    2. Miller SJ

    . A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 2015;15:290–301 doi:10.1038/nrc3911 pmid:25877329

    CrossRefPubMed
15. 15.↵
    1. Chen C-C,
    2. Hsu P-W,
    3. Wu T-WE, et al

    . Stereotactic brain biopsy: single center retrospective analysis of complications. Clin Neurol Neurosurg 2009;111:835–39 doi:10.1016/j.clineuro.2009.08.013 pmid:19765887

    CrossRefPubMed
16. 16.↵
    1. Dammers R,
    2. Haitsma IK,
    3. Schouten JW, et al

    . Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 2008;150:23–29 doi:10.1007/s00701-007-1473-x pmid:18172567

    CrossRefPubMed
17. 17.↵
    1. Hall WA

    . The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82:1749–55 doi:10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2 pmid:9576298

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kongkham PN,
    2. Knifed E,
    3. Tamber MS, et al

    . Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci 2008;35:79–84 doi:10.1017/s0317167100007605 pmid:18380282

    CrossRefPubMed
19. 19.↵
    1. Gill DS,
    2. Hyman SL,
    3. Steinberg A, et al

    . Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 2006;36:1048–56 doi:10.1007/s00247-006-0267-2 pmid:16912896

    CrossRefPubMed
20. 20.↵
    1. Sevick RJ,
    2. Barkovich AJ,
    3. Edwards MS, et al

    . Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 1992;159:171–75 doi:10.2214/ajr.159.1.1609692 pmid:1609692

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Lucchetta M,
    2. Manara R,
    3. Perilongo G, et al

    . Regression of gadolinium-enhanced lesions in patients affected by neurofibromatosis type 1. Radiol Med 2016;121:214–17 doi:10.1007/s11547-015-0587-0 pmid:26445946

    CrossRefPubMed
22. 22.↵
    1. Hyman SL,
    2. Gill DS,
    3. Shores EA, et al

    . Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 2003;60:1139–45 doi:10.1212/01.WNL.0000055090.78351.C1 pmid:12682321

    Abstract/FREE Full Text
23. 23.↵
    1. Salman MS,
    2. Hossain S,
    3. Alqublan L, et al

    . Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 1—clinical and neuroimaging findings. Cerebellum Ataxias 2018;5:14 doi:10.1186/s40673-018-0093-y pmid:30410779

    CrossRefPubMed
24. 24.↵
    1. Van Es S,
    2. North KN,
    3. McHugh K, et al

    . MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 1996;26:478–87 doi:10.1007/BF01377205 pmid:8662066

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Morris PW,
    2. Glasier CM,
    3. Smirniotopoulos JG, et al

    . Disappearing enhancing brain lesion in a child with neurofibromatosis type I. Pediatr Radiol 1997;27:260–61 doi:10.1007/s002470050118 pmid:9126587

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Ullrich NJ,
    2. Raja AI,
    3. Irons MB, et al

    . Brainstem lesions in neurofibromatosis type 1. Neurosurgery 2007;61:762–66; discussion 766–67 doi:10.1227/01.NEU.0000298904.63635.2D pmid:17986937

    CrossRefPubMed
27. 27.↵
    1. Margari L,
    2. Presicci A,
    3. Ventura P, et al

    . Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1. J Child Neurol 2006;21:1085–90 doi:10.1177/7010.2006.00124 pmid:17156707

    CrossRefPubMed
28. 28.↵
    1. Vinhais S,
    2. Nunes S,
    3. Salgado D

    . Focal brain enhancing lesions of evanescent type in patients with neurofibromatosis-1. ECR 2013 PosterNG 2013
29. 29.↵
    1. Raininko R,
    2. Thelin L,
    3. Eeg-Olofsson O

    . Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1. Neuropediatrics 2001;32:225–30 doi:10.1055/s-2001-19115 pmid:11748492

    CrossRefPubMed
30. 30.↵
    1. Mimouni-Bloch A,
    2. Kornreich L,
    3. Kaadan W, et al

    . Lesions of the corpus callosum in children with neurofibromatosis 1. Pediatr Neurol 2008;38:406–10 doi:10.1016/j.pediatrneurol.2008.02.010 pmid:18486822

    CrossRefPubMed
31. 31.↵
    1. Miller DT,
    2. Freedenberg D,
    3. Schorry E, et al

    . Health supervision for children with neurofibromatosis type 1. Pediatrics 2019;143:e20190660 doi:10.1542/peds.2019-0660 pmid:10206167

    Abstract/FREE Full Text
32. 32.↵
    1. Gottschalk S,
    2. Tavakolian R,
    3. Buske A, et al

    . Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases. Neuroradiology 1999;41:199–201 doi:10.1007/s002340050734 pmid:10206167

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Menor F,
    2. Marti-Bonmati L,
    3. Arana E, et al

    . Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol 1998;26:121–31 doi:10.1016/S0720-048X(97)00088-0 pmid:9518221

    CrossRefPubMed
34. 34.↵
    1. Parsa CF,
    2. Hoyt CS,
    3. Lesser RL, et al

    . Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001;119:516–29 doi:10.1001/archopht.119.4.516 pmid:11296017

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Leisti EL,
    2. Pyhtinen J,
    3. Poyhonen M

    . Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996;17:1691–94 pmid:8896624

    Abstract
36. 36.↵
    1. Cakirer S,
    2. Karaarslan E

    . Spontaneous involution of a non-optic astrocytoma in neurofibromatosis type I: serial magnetic resonance imaging evaluation. Acta Radiol 2004;45:669–73 doi:10.1080/02841850410001150 pmid:15587427

    CrossRefPubMed
37. 37.↵
    1. Hegde AN,
    2. Mohan S,
    3. Lath N, et al

    . Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. RadioGraphics 2011;31:5–30 doi:10.1148/rg.311105041 pmid:21257930

    CrossRefPubMedWeb of Science